WaveMan
WaveMan · Company
GENI · Genius Sports Ltd
> Search tickers & screens ⌘K
LIVE
← All companies

GENI Genius Sports (GENI) Insider Trading, Ownership & Congress Trades

Restaurants & Leisure · Services-miscellaneous amusement & recreation · CIK 0001834489
Quote by TradingView
Form 144 · 1
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
178
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · no price filed

What the filings say about GENI

Insiders, 180 days
-$5.6M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$325.6K
1 notice

Genius Sports insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Genius Sports Ltd insiders sold a net $5.6M of stock across 4 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.

Insider
Filed
Shares
Value
Since filing
Locke Mark
Chief Executive Officer
SELL
2026-09-17 SEC
50,000
$327.1K
+15.6%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Sep 16, 2026.
  • The trade is 0.3% of the 19,375,216 shares held after it.
  • 1 other insider sold within 30 days.
  • 178 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Locke Mark sold about $327.1K of GENI on Sep 17, 2026; 1 other insider sold within 30 days and 178 funds added in the latest 13F quarter.
Russell Thomas
Chief Legal Officer
SELL
2026-09-18 SECtraded 2026-09-17
50,000
$325.6K
+13.2%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 10.6% of the 471,467 shares held after it.
  • 1 other insider sold within 30 days.
  • 178 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Russell Thomas sold about $325.6K of GENI on Sep 17, 2026; 1 other insider sold within 30 days and 178 funds added in the latest 13F quarter.
Locke Mark
Chief Executive Officer
SELL
2026-09-17 SECtraded 2026-09-16
272,551
$1.8M
+15.6%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Sep 15, 2026.
  • The trade is 1.4% of the 19,425,216 shares held after it.
  • 1 other insider sold within 30 days.
  • 178 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Locke Mark sold about $1.8M of GENI on Sep 16, 2026; 1 other insider sold within 30 days and 178 funds added in the latest 13F quarter.
Locke Mark
Chief Executive Officer
SELL
2026-09-17 SECtraded 2026-09-15
477,449
$3.1M
+15.6%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 2.4% of the 19,697,767 shares held after it.
  • 1 other insider sold within 30 days.
  • 178 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Locke Mark sold about $3.1M of GENI on Sep 15, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days and 178 funds added in the latest 13F quarter.
4 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$5.6M over 180 days
-$5.6M over 90 days
below 71% of Restaurants & Leisure
Congress
no House purchase disclosed in the last 12 months
Funds
178 funds bought in last quarter
more than 66% of Restaurants & Leisure
Revenue
+31.0% year over year
more than 90% of Restaurants & Leisure
Margin
-16.7% net margin
below 80% of Restaurants & Leisure
Buybacks
no share repurchases reported
Short interest
19.6% of the float short (float per yahoo 2026-10-27) · 5.7 days to cover · settled 2026-10-15
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch GENI

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-45.7%12M
-67%-45%-22%+0%2025-102025-122026-022026-042026-062026-082026-10 2026-09-15 · Locke Mark sold $3.1M2026-09-16 · Locke Mark sold $1.8M2026-09-17 · Locke Mark sold $327.1K2026-09-17 · Russell Thomas sold $325.6K2026-09-17 · Russell Thomas filed to sell $325.6K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns GENI: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
19,774,779 sh
$119.8M
Senvest Management, LLC
15,881,616 sh
$96.2M
GLENVIEW CAPITAL MANAGEMENT, LLC
13,495,287 sh
$81.8M
Hood River Capital Management LLC
12,929,769 sh
$78.4M
Stephens Investment Management Group LLC
10,691,861 sh
$64.8M

Congress trades in GENI

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

GENI planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Russell Thomas
Filed 2026-09-17
$325.6K

GENI mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
FULLERTHALER BEHAVIORAL MICRO-CAP EQUITY FUND
$490.9K position · as of 2026-06-30
1.6%
Needham Aggressive Growth Fund
$28.8M position · as of 2026-06-30
1.1%
WCM Focused International Equity Fund
$2.6M position · as of 2026-06-30
1.0%
ACUITAS US MICROCAP FUND
$520.3K position · as of 2026-06-30
0.4%
Victory Small Cap Stock Fund
$1.9M position · as of 2026-07-31
0.2%
SEI Select Small Cap ETF
$1.1M position · as of 2026-06-30
0.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $5.6M sold by insiders over 180 days, 178 funds added last quarter, $325.6K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
BROSTKODKNGCMGSGACELHBUKSQSRRSILYVCVEO

GENI financials

Revenue growth
+31.0%
XBRL, annual
Net margin
-16.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Debt to equity
0.00x
LongTermDebt as filed 2024-12-31 (includes the current portion); equity 2025-12-31
Cash flow to debt
n/a
needs four quarters of operating cash flow
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
-$215.3M
market value at close 2026-10-26 on 2025-12-31 shares, plus LongTermDebt as filed 2024-12-31 (includes the current portion), minus cash 2025-12-31
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$669.5M$510.9M$413.0M$341.0M
Gross profit$153.8M$128.7M$69.0M$2.9M
Operating income-$151.3M-$58.5M-$74.2M-$182.9M
Net income-$111.6M-$63.0M-$85.5M-$181.6M
EPS (diluted)-0.44-0.27-0.38-0.85
Operating cash flow$86.4M$81.9M$14.9M-$3.5M
Cash$280.6M$110.2M$100.3M$122.7M
Long-term debtn/a$19.0K$19.0K$7.1M
SEC XBRL, fiscal years, as known on 2026-10-28

GENI Stock Sonar score 5/7 axes

Find similar shapesCompare

GENI ranks highest on financial health (98th percentile) and institutional and government (66th), and lowest on risk and compliance (11th), among Restaurants & Leisure peers.

HealthGrowthInsidersInstitutionsRisk
Financial health
98
Inputs
  • Debt to equity0.00x · 98 pct, sector of 95
  • Cash flow to debtneeds four quarters of operating cash flow
Growth
56
Inputs
  • Revenue growth, YoY+31.0% · 90 pct, sector of 143
  • Backlog growth, YoY-22.5% · 22 pct, sector of 33
Insider conviction
15
Inputs
  • Net Form 4 buying (codes P and S), 180d-$5.6M · 30 pct, sector of 77
  • Insider buyers, 180d0 · 0 pct, sector of 77
Institutional and government
66
Inputs
  • Funds adding, latest quarter178 · 66 pct, sector of 112
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
11
Inputs
  • Short interest, % of float+19.6% · 11 pct, sector of 149
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Profitability, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

GENI filings, in plain words

Are Genius Sports insiders buying or selling GENI?

In the 180 days to 2026-10-28, Genius Sports insiders were net sellers, a net $5.6M across purchases and sales reported on Form 4, by 2 sellers.

Are there planned insider sales of GENI?

Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $325.6K of stock; the latest, by Russell Thomas, was filed 2026-09-17.

Read the full summary

In the 180 days to 2026-10-28, Genius Sports insiders were net sellers of GENI, a net $5.6M across purchases and sales reported on Form 4 by 2 sellers. None of the 4 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $325.6K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies